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Abstract
Background: Cytosine methylation of DNA is conserved across eukaryotes and plays important functional roles
regulating gene expression during differentiation and development in animals, plants and fungi.
Hydroxymethylation was recently identified as another epigenetic modification marking genes important for
pluripotency in embryonic stem cells.
Results: Here we describe de novo cytosine methylation and hydroxymethylation in the ciliate Oxytricha trifallax.
These DNA modifications occur only during nuclear development and programmed genome rearrangement.
We detect methylcytosine and hydroxymethylcytosine directly by high-resolution nano-flow UPLC mass
spectrometry, and indirectly by immunofluorescence, methyl-DNA immunoprecipitation and bisulfite sequencing.
We describe these modifications in three classes of eliminated DNA: germline-limited transposons and satellite
repeats, aberrant DNA rearrangements, and DNA from the parental genome undergoing degradation. Methylation
and hydroxymethylation generally occur on the same sequence elements, modifying cytosines in all sequence
contexts. We show that the DNA methyltransferase-inhibiting drugs azacitidine and decitabine induce
demethylation of both somatic and germline sequence elements during genome rearrangements, with
consequent elevated levels of germline-limited repetitive elements in exconjugant cells.
Conclusions: These data strongly support a functional link between cytosine DNA methylation/hydroxymethylation
and DNA elimination. We identify a motif strongly enriched in methylated/hydroxymethylated regions, and we
propose that this motif recruits DNA modification machinery to specific chromosomes in the parental
macronucleus. No recognizable methyltransferase enzyme has yet been described in O. trifallax, raising the
possibility that it might employ a novel cytosine methylation machinery to mark DNA sequences for elimination
during genome rearrangements.
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Background
DNA methylation is an epigenetic mark that alters gene
expression and regulates genome stability in plants, ani-
mals and fungi [1-5]. As a stable, heritable repressive mark
that is copied faithfully during DNA replication, DNA
methylation of cytosine is crucial for the specification of
cell lineages in mammalian and plant development
[2-4,6,7]. Demonstrating their essential functional roles,
mutations in DNA methyltransferases (Dnmts) are lethal
in mice and frogs [8-10], while mutations of the de novo
methyltransferase Dnmt3a/b cause developmental disease
in humans [11,12]. DNA methylation induces and rein-
forces the formation of heterochromatin, which is a tightly
packed form of chromatin associated with the repression
of transcription [2,4,13]. The most widely-studied regula-
tory methylation occurs at gene promoters, in CpG-rich
regions termed ‘CpG islands’ [14,15], where it induces a
transcriptionally silent epigenetic state that is inherited
faithfully in descendant cells [4]. For example, the promo-
ter of the stem cell pluripotency gene Oct-4 becomes
methylated in differentiating cells, which leads to silencing
and a block to reprogramming other stem cell fates in all
cell progeny [16,17]. Another example is the development
of the vertebrate immune system, in which cascades of
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transcription factors control cell fates; these fates are
locked in by de novo DNA methylation of target gene pro-
moters (reviewed in [18]). DNA methylation also plays a
key role in oncogenic transformation: it has been known
for over 15 years that cancer cell genomes display gen-
ome-wide abnormalities in DNA methylation patterns
[19-23], some of which have been shown to be oncogenic
[24] and to contribute to genome instability [25]. In parti-
cular, de novo methylation of tumor suppressor gene pro-
moters occurs frequently in cancers, thereby silencing
them and promoting transformation [19,21,22].
Oxytricha trifallax is a ciliated protist that performs
genetic gymnastics in a complex developmental program
to disentangle its genome [26]. Each cell contains two
distinct types of nuclei: a germline micronucleus (MIC)
that is usually transcriptionally silent, and a transcription-
ally-active somatic macronucleus (MAC) that derives from
the MIC but retains only 5% of its sequences [27]. The pro-
cess of MAC development involves elimination of repeti-
tive elements such as transposons [28-30] and satellite
repeats [31]. In the developing, or zygotic, MAC, genes are
reconstructed from relatively short segments, known as
Macronuclear Destined Segments (MDSs), which are
stitched together, often in a different order relative to their
original order in the MIC, to produce nanochromosomes
that typically contain only a single gene [26]. Genes are
frequently interrupted by spacer sequences, known as
Internal Eliminated Sequences (IESs), that are removed
from the genome during the rearrangement process. MAC
nanochromosomes are, on average, a little over 2 kb long,
and there are approximately 20,000 different chromosomes
in each macronucleus [26]. During the developmental
process of genome rearrangement, one MIC genome irre-
versibly differentiates into a new, zygotic MAC, and the
old, parental MAC genome degrades.
Oxytricha cells thus have to eliminate two sets of DNA
during development of the zygotic MAC: the entirety of
the parental MAC genome and the vast majority (95%) of
the MIC genome (Figure 1) [26,27,32,33]. Here we present
data that implicate DNA methylation and hydroxymethy-
lation in both DNA degradation processes. Furthermore,
we describe a type of DNA methylation/hydroxymethyla-
tion whose defining characteristic is modification of every
cytosine in a local region of a chromosome in a context-
independent fashion, as opposed to modification of speci-
fic motifs. This pan-cytosine modification in O. trifallax is
consistent with a model in which methylation marks DNA
segments for elimination (possibly through degradation
into nucleotides, which are then released into the media
[34]). We present functional data linking DNA methyla-
tion to the highly regulated and essential process of
genome rearrangement in O. trifallax. Given that no
recognizable methyltransferase enzyme has yet been
described in O. trifallax, it is possible that this unusual
methylation may be deposited by novel methylation
machinery.
The identification of cytosine methylation and hydroxy-
methylation as a degradation signal for DNA is novel
although not entirely surprising, because the distantly
related ciliate Tetrahymena thermophila uses repressive
chromatin marks, including histone methylation of H3K27
[35] deposited by an Enhancer of Zeste (E(z)) homolog
[36], along with several chromatin-recognizing proteins
[37-39], to mark DNA for degradation. In addition, E(z)
homologs (specifically, EZH2) in humans are known to
recruit DNA methyltransferases [40]. However, neither
DNA methylation nor hydroxymethylation has previously
been implicated in a eukaryotic DNA degradation process.
Therefore, the observations presented here significantly
expand our understanding of functional roles for DNA
methylation and hydroxymethylation in biology.
Results
Immunofluorescence reveals that cytosine methylation is
specific to conjugation
To investigate the role of cytosine methylation in genome
rearrangements, we harvested cells 46 h (hours) post-
conjugation, fixed them and performed immunofluores-
cence against 5-methylcytosine (Figure 2a). Methylcyto-
sine immunofluorescence signal was observed only in the
degrading parental macronucleus of 46 h exconjugant
cells and not in vegetative cells (Figure 2a). In the 46 h
population of cells, only half contained detectable methyl-
cytosine signal above background. However, it was possi-
ble to sort these cells by developmental stage based on
nuclear morphology, and we designate these internal
stages S0, for vegetative cells, and S1 through S4 for
conjugating cells (see Figure 2e for criteria). Because
O. trifallax cultures cannot be perfectly synchronized, the
oldest cells (S4) are 46 h post-conjugation, but other cells
are younger, and the youngest cells, a minority of the
population, are approximately 30 h post-conjugation (S1),
as determined by co-immunofluorescence with the tem-
poral marker Otiwi1, a PIWI homolog (Figure 2d). These
data show that methylcytosine does not localize in paren-
tal MAC until after Otiwi1 immunostaining is strongly
reduced at approximately 40 h. In between S1 and S4 it
is possible to distinguish two more stages based on the
number of parental macronuclei and the size of the
developing zygotic macronucleus (Figure 2a,b,e). These
stages (S2 and S3) appear to correspond to approximately
36 and 40 h post-conjugation, respectively. Notably, the
percentage of cells exhibiting cytosine methylation of the
parental macronucleus rises to 75% and 100% in S2 and
S3 cells, respectively, but drops to zero when the parental
macronucleus is completely eliminated in S4 (46 h) cells
(Figure 2a,b,e). These data suggest a model in which
DNA degradation is signaled by significant cytosine
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methylation. Modified chromosomes of the parental
macronucleus are eliminated along with their epigenetic
DNA modifications during the degradation process. Due
to the imprecision of the synchrony of O. trifallax cells,
this process can be captured in the range of cells
observed at a single timepoint (46 h) post-conjugation;
the full methylation-degradation process appears to
occupy only approximately 8-10 h (Figure 2e).
Hydroxymethylcytosine is an epigenetic mark only
recently recognized as a biologically important modifica-
tion, with roles distinct from DNA methylation [41,42].
We performed immunofluorescence with an anti-hydroxy-
methylcytosine antibody in O. trifallax (Figure 2b) and
found detectable levels of this modification that overlap
completely with DNA methylation (Figure 2b). In general,
the methylcytosine immunofluorescense signal is more
robust, but hydroxymethylcytosine consistently localizes to
the same parental MAC in cells approximately 36-40 h
post-conjugation. While methylation was not observed in
any cells after S4 (when the parental MAC is eliminated),
we consistently noted a faint hydroxymethylation signal in
the zygotic MAC at this late stage cell (see the 57 h cell in
Figure 2b).
Detection of cytosine methylation and
hydroxymethylation by mass spectrometry
The detection of cytosine methylation in organisms lacking
methyltransferase enzymes has proven contentious.
Because the modifications reported here are transient, and
because we have not yet identified a cytosine methyltrans-
ferase enzyme in O. trifallax, we definitively confirmed the
presence of cytosine methylation and hydroxylmethylation
through direct detection by ultra high performance liquid
chromatography (UPLC)-high-resolution mass spectrome-
try (MS) (Figure 3). To accomplish this, we subjected geno-
mic DNA harvested from O. trifallax at various time points
post-conjugation to degradation into nucleosides by treat-
ment with nuclease and phosphatase enzymes. As a positive
control and standard for the detection of 5-methylcytidine,
5-hydroxymethylcytidine and cytidine, we used enzymati-
cally degraded PCR products obtained from PCR reactions
containing fully cytosine-methylated, hydroxymethylated or
non-methylated constituents. We subjected these free
nucleosides to UPLC-MS using a capillary nano-flow
UPLC system hyphenated to a high mass accuracy, high-
resolution Orbitrap-based MS platform. This approach
yielded chromatographic resolution of the nucleosides and
Figure 1 Overview of the genome rearrangement process in Oxytricha trifallax and approximate timing of major events. The two red
Xs mark the degradation of two populations of DNA molecules during the genome rearrangement process. The macronucleus (MAC) and
micronucleus (MIC) are both depicted.
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modified nucleosides into their characteristic reversed-
phase elution profiles, and enabled unambiguous confirma-
tion of nucleoside identities by the accurate mass measure-
ment of the Orbitrap mass spectrometer, which specified
their atomic composition.
O. trifallax samples not only displayed the presence of
both 5-methylcytidine (Figure 3b) and 5-hydroxyl-
methylcytidine (Figure 3c), but also revealed temporal
dynamics in abundance that were similar to those
observed by immunofluorescence (Figure 2a,b). Relative
Figure 2 Immunofluorescence of fixed Oxytricha trifallax cells during genome rearrangements. (a) A methylcytosine signal appears
during the 30-40 h (hour) window. Cells are staged by the nuclear morphology observed in single, well-timed cells. The micronucleus (I),
parental macronucleus (A) and zygotic macronucleus (Z) are all indicated. (b) Co-immunofluorescence analysis shows co-localization of
methylcytosine and hydroxymethylcytosine. (c) Quantification of methylcytosine-containing DNA-rich bodies (the parental macronucleus) in the
46 h population shown in (a), separated by cell stage. (d). Co-immunofluorescence with methylcytosine and anti-Otiwi1, a temporal marker for
zygotic macronucleus development. Note the temporal separation of Otiwi1 and DNA methylation during the transition between S1 and S3.
(e) The nuclear morphology criteria used in (a) - (d) for staging cells. MAC, macronucleus; Veg, vegetative.
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Figure 3 Direct detection of 5-methylcytidine and 5-hydroxymethylcytidine in Oxytricha trifallax DNA using high-resolution nano-flow
UPLC-mass spectrometry. Nucleosides generated from purified O. trifallax DNA isolated 0 h, 36 h, 40 h and 64 h post-conjugation, or from
standards (synthetic PCR products containing either unmodified nucleosides, 5-methylcytidine or 5-hydroxymethylcytidine), were subjected to
LC-MS on a high-resolution nano-flow UPLC - Orbitrap mass spectrometry platform. Extracted chromatograms of the (a) cytidine,
(b) 5-methylcytidine and (c) 5-hydroxymethylcytidine [M+H]+ ions are shown, displaying a single prominent peak for each molecular species
across the chromatographic timescale. Inset into the chromatograms are mass spectra of the detected [M+H]+ ion for each molecular species;
empirical mass measurements for these ions were each within ±0.0005 Da of theoretical values for cytidine, 5-methylcytidine and 5-
hydroxymethylcytidine atomic compositions.
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5-methylcytidine amounts increased sharply 36 h post-
conjugation over vegetative levels, and then underwent a
progressive decrease at the 40 h and 64 h time points
(Figure 3b). In contrast, 5-hydroxylmethylcytidine was
undetectable at the 36 h time point and only became
detectable at 40 h post-conjugation, remaining elevated
through the 64 h time point (Figure 3c). Both differed
from unmodified cytidine levels, which were expectedly
high and approximatelu equivalent throughout all time
points (Figure 3a). The mass spectrometry data are pub-
licly available at OxyDB, the O. fallax genome database
[43].
Deep sequencing of methylated DNA in the
macronucleus and micronucleus
The immunofluorescence results and confirmation by mass
spectrometry motivated a genome-wide search for
sequences that become methylated specifically during
genome rearrangement. We chose to use methyl-DNA
immunoprecipitation coupled with deep sequencing
(meDIP-seq) [44-52] to identify specific locations in the
genome enriched for methylcytosine or hydroxymethylcyto-
sine. Two Illumina sequencing libraries were constructed,
one from vegetative cells, to act as a non-methylated/non-
hydroxymethylated control, and one from 46 h post-
conjugation DNA isolated from the same cells imaged in
Figure 2a. Immunoprecipitation was performed as described
[44], with either an IgG control, the methylcytosine anti-
body used for immunofluorescence (Figure 2) [53] or an
antibody to hydroxymethylcytosine [54]. The immunopreci-
pitated material was subjected to high-throughput sequen-
cing, from which between 5 million and 9 million reads
were obtained from each library, sufficient to provide 10- to
20-fold coverage of the MAC genome. The mapped reads
were normalized for total read number (sequencing depth
of each library) and chromosome/contig length, providing a
reasonable abundance estimate for each genomic sequence
(as reads per kb per million reads, or RPKM).
To establish the accuracy of our approach we plotted
RPKM from vegetative IgG versus 46 h IgG, thereby visua-
lizing the difference in copy number between conjugating
and vegetative cells (Figure 4a). In this chart, each chro-
mosome is represented by a point on a scatterplot, and
two patterns are evident: a 46 hr-to-vegetative line with a
slope of 1 (R2 = 0.937), which contains the MAC chromo-
somes of O. trifallax at equal abundance in both vegetative
and 46 h cells, and other sequences that are approximately
five-fold enriched at 46 h relative to vegetative DNA (R2 =
0.965) (Figure 4a). The 46 hr enriched sequences (blue tri-
angles in Figure 4a) comprise MIC sequences that have
not been filtered out of the MAC genome assembly; they
lack terminal telomeres and consist of either repetitive
satellite sequences or TBE (telomere bearing element)
transposons, a Tc1/mariner class of transposons abundant
in the O. trifallax micronuclear genome and eliminated
during genome rearrangements.
During the O. trifallax sexual cycle (Figure 1), the MIC
genome becomes amplified into polytene chromosomes
prior to genome rearrangement and fragmentation into
nanochromosomes. Published work supports polyteniza-
tion of approximately 15-fold, reaching maximum ampli-
fication 40-50 h post-conjugation [26,33,34,55,56]. Given
that our data suggest that the amplification at 46 h post-
conjugation is approximately five-fold higher than that
of vegetative cells, we conclude that our conjugating
O. trifallax population had not reached full polyteniza-
tion at the 46 hr timepoint, but that it was within two
DNA replication cycles of maximal amplification. In
total, there were 58 MIC-limited 46 hr-enriched contigs
in the genome assembly, and these were extracted from
the MAC genome and analyzed separately in all sub-
sequent analysis. The ability to separate out known (and
novel) MIC contigs from the MAC genome assembly con-
firms the general accuracy of the meDIP-seq approach for
measuring DNA levels in a sample. Therefore, we turned
next to analysis of the methylcytosine and hydroxymethyl-
cytosine immunoprecipitation data.
Analysis of the meDIP data is complicated by two factors:
firstly, the tendency of the methylcytosine and hydroxy-
methylcytosine antibodies to bind, albeit weakly, to unmo-
dified cytosine; and, secondly, the tendency of a given
genomic sequence to bind non-specifically to the beads or
to constant portions of the antibody. These phenomena
generate noise in the meDIP-seq data (Figure 5b,c), which
was filtered out in a two-step normalization process by
taking advantage of the fact that neither methylcytosine
nor hydroxymethylcytosine is detected in vegetative cells
(Figures 2a and 3b,c). In the first step, the 46 hr reads were
normalized for total read number and chromosome length,
to give an RPKM value. In the second step, the RPKM
value obtained with the same antibody from the vegetative
cells, in which methylation and hydroxymethylation were
not present, was subtracted from the first value. This nor-
malization procedure was performed for the methylcyto-
sine, hydroxymethylcytosine and IgG data, removing the
majority of the noise in all three datasets. We designate
each residual dataset, obtained by subtracting vegetative
reads from 46 h reads, the ‘signal’ for the corresponding
antibody (methylcytosine, hydroxymethylcytosine or IgG).
In examining the methylcytosine versus IgG signal in
MAC, most chromosomes are clustered at zero on both
axes (Figure 4b). Surprisingly, these data suggest that
the majority of the MAC genome does not display
detectable levels of cytosine methylation at 46 h. How-
ever, a skew of MAC chromosomes exhibiting an excess
of reads from the 46 h sample is evident (Figure 4c).
There is a natural break in the distribution separating
eleven chromosomes with over 100 excess reads (dotted
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Figure 4 Methyl-DNA-immunoprecipitation sequencing (meDIP-seq) analysis of DNA from 46 h conjugating cells shown in Figure 2. All reads
are presented in reads per kb per million (RPKM) to correct for length of sequences and sequencing depth. (a) IgG controls for both vegetative (x-axis)
and 46 h DNA (y-axis). Micronuclear sequences are polyploid at the 46 h stage due to polytenization of chromosomes prior to genome rearrangements,
and fall along a 5:1 gradient, shown as a dashed line. (b) Heatmap of methylcytosine immunoprecipitation (meCyt) reads with vegetative reads
subtracted; IgG on the x-axis and methylcytosine on the y-axis. (c) A scatter plot to highlight the outliers along the y-axis in (b). The dotted line denotes
the threshold (100 excess reads in 46 h meCyt) used to define the methylation cohort. These 11 chromosomes were fed into the MEME algorithm,
which identified the CC motif on the right, which was highly statistically significant (MEME e-value = 2.8e-236); control cohorts of chromosomes were
selected from the un-enriched population (middle) and depleted population (bottom): no motifs were found and the highest scoring motif in these
cases was the telomeric sequence, G4T4G4T4G4. (d) Hydroxymethylcytosine (x-axis) versus methylcytosine (y-axis) immunoprecipitation data.
Nanochromosomes encoding ribosomal proteins or the ribosomal RNA are shown as cyan diamonds; the rest of the nanochromosomes in the genome
are plotted as red circles. Note co-enrichment of the methylation cohort with both methyl- and hydroxymethyl- modifications, and that the
chromosomes encoding ribosomal RNA and ribosomal proteins are only enriched for hydroxymethylcytosine. (e) The same analysis as (b) and (c), but
for micronuclear contigs separated from the genome assembly in (a). Representative satellite repeats (labeled with their repeat unit length) and TBE
elements display a complex mixture, suggesting a heterogeneous combination of DNA modifications in the genome. The strong
hydroxymethylcytosine signal for the 170 bp satellite repeat (10,953 hmCyt reads, x-axis; 4,166 meCyt reads, y-axis; Additional file 3) placed it outside the
bounds of this figure. (f) Venn diagram of the methylation (mC) cohort, hydroxymethylation (hmC) cohort and CC motif cohort. (g) All 69 CC motif-
containing chromosomes plotted with their methylation and hydroxymethylation signals from meDIP-seq data. IgG, immunoglobulin G; MEME, Multiple
Em for Motif Election; TBE, telomere bearing element; Veg, vegetative.
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line in Figure 4c) in the methylcytosine library. We
therefore separated these chromosomes into a methyla-
tion cohort group for further analysis. This group of
chromosomes encodes several predicted proteins of
potential functional interest (Additional file 1), including
DNA-binding proteins (an Alba protein, a zinc finger
protein, and a TFIIA transcription factor), RNA-binding
proteins (an RRM (RNA recognition motif)-containing
protein and an LSm (Sm-like) domain-containing pro-
tein), and protein kinases. However, the reasons why
these chromosomes might be preferentially methylated
were not immediately clear from the intial analysis of
our meDIP data. We therefore further analyzed these
methylcytosine-enriched chromosomes for specific
motifs by using the Multiple Em for Motif Election
(MEME) software package [57].
A highly significant 20 bp-long pyrimidine-rich motif
(MEME e-value = 2.8e-236) was identified in the methyla-
tion cohort chromosomes and not detected in control
cohorts of eleven MAC chromosomes lacking enrichment
in 46 h DNA (selected from the center of the distribution,
the middle group in Figure 4c) or enriched in vegetative
DNA (bottom group in Figure 4c). Due to the recurrence
of CC in this motif, we termed it the ‘CC motif’. The motif
appears to be bipartite, with strong C-rich signals reaching
maximum information content approximately 10 bp apart,
which suggests a separation of one turn of the DNA helix
(Figure 4c). The CC motif was present an average of five
times on each methylation cohort chromosome, generally
occurring in clusters (59 statistically significant motifs were
present on eight of the eleven chromosomes). Of additional
interest was the apparent correlation between the CC motif
and the meDIP-seq data for those eight chromosomes that
contained the motif; the motif mapped, in most cases, to
the majority of observed peaks (Figure 5a). Three of the
eleven methylation cohort chromosomes did not contain
the motif, and it may be that these chromosomes instead
contained more divergent instances of the motif that were
less confidently identified by MEME, although the exis-
tence of other methylation-targeting motifs cannot be
excluded. The fact that some meDIP-seq peaks did not cor-
relate with the motifs in Figure 5a also supports the idea
that additional methylation-targeting motifs remain uni-
dentified in the analysis presented here.
To investigate the potential role of the CC motif
further, we carried out a genome-wide scan to identify
additional occurrences, using a stringent false-discovery
rate of 1 × 10-7 (that is, one false discovery per 10 million
occurrences of the motif). Genome-wide, we observed
229 instances of the motif, on a total of 69 chromosomes,
61 of which were not in the methylation cohort. Further-
more, we observed that chromosomes with 3 or more CC
motifs were also enriched for both methylcytosine and
hydroxymethylcytosine at the 46 h timepoint (Figure 4g),
so we label these 25 chromosomes (with 3 or more
motifs) the CC motif cohort (Additional file 2).
The CC-motif cohort includes additional, potentially
informative candidates, including 3 new Alba genes,
bringing the total identified in our methylation analysis
to five (two were in the methylation cohort, Additional
file 1). There was an overall enrichment in DNA- and
RNA-binding proteins in this CC motif cohort (Addi-
tional file 2). Strikingly, both O. trifallax genes encoding
fibrillarin were identified in the CC-motif scan, with 3
CC motifs each (Additional file 2).
The hydroxymethylcytosine immunoprecipitation data
yielded a similar picture to the methylcytosine immuno-
precipitation, but there were also important differences.
We performed a ranking of MAC chromosomes by their
hydroxymethylcytosine signal, with minimum thresholds
of 40 excess 46 h reads and a hydroxymethylation-to-IgG
signal ratio of 1.5 (Additional file 3). Remarkably, we
found that 9 of 11 methylation cohort chromosomes were
also present in the hydroxymethylation cohort of 29 MAC
genes (Additional file 3). The top member is the same on
both lists (unknown protein-encoding chromosome Con-
tig2927.0), but the other overlapping members are mostly
present in a slightly different order. In addition, several
new chromosomes appear in the hydroxymethylation
cohort, with ribosomal RNA chromosomes (two isoforms
of the same genetic sequence) appearing second and third.
Three ribosomal protein-encoding genes also appeared in
the hydroxymethylation but not the methylation cohort.
Several additional ribosomal protein genes were relatively
more hydroxymethylated than methylated (Figure 4d, cyan
diamonds).
The MIC genome contains many short repeats (J.R.B.,
L.F.L, manuscript in preparation). One of the most abun-
dant has a 170 bp repeat unit that is completely elimi-
nated from the developing macronucleus during genome
rearrangement [31]. This repeat was strongly enriched in
hydroxymethylcytosine meDIP data (Additional file 3).
In addition, several other satellite repeats were also sig-
nificantly enriched for hydroxymethylcytosine relative to
methylcytosine (Additional file 3). Methylation was
detected strongly on a different set of MIC sequences
comprising different satellite repeats (shown in Addi-
tional file 1 and Figure 4e, with their repeat unit lengths)
and a TBE2 transposase sequence (Additional file 1,
Figure 4e). We conclude that repetitive MIC-limited
sequences, such as satellite DNA and transposons, may
be preferentially modified by hydroxymethylcytosine or
methylcytosine, or both (Figure 4e, Additional files 1
and 3).
The meDIP sequencing read data and genome-wide
mapping analysis are publicly available [GEO: GSE41060].
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Figure 5 Visualization of meDIP-seq data mapped to select Oxytricha trifallax chromosomes. (a) 46 hour methylcytosine
immunoprecipitation reads mapped to the methylation cohort of eleven chromosomes (Figure 4c, above the dotted line). Read depth is
represented by the peaks in the y dimension for each chromosome (scale not comparable between chromosomes). CC motifs are shown as
purple arrowheads below the reads for each chromosome. The gold bar represents the ORF, consistently oriented from left to right in all
chromosomes. Teal arrows indicate oligos used in bisulfite-PCR, while grey arrows shown above the ORF indicate oligos used in bisulfite-qPCR.
(b) Scaled plot of Contig2927.0 meDIP-seq signal, the highest ranking chromosome in both the methylation and hydroxymethylation cohorts, for
immunoprecipitation with IgG, methylcytosine (mC) and hydroxymethylcytosine (hmC) in both vegetative (negative control) and 46 h DNA. One
million reads from each library were plotted at equal scales, so that the heights of peaks (and read numbers) are directly comparable. (c) Scaled
plot of TEBPb showing enrichment both for methylcytosine (mC) and hydroxymethylcytosine (hmC), with plotting and scaling as in (b). Dark
lines under 46 h mC and hmC plots represent the methylated/hydroxymethylated aberrantly spliced product identified by bisulfite-PCR (shown
in Figure 6d,e). ORF, open reading frame; qPCR, quantitative PCR; TEBPb, Telomere End-Binding Protein b; Veg, vegetative.
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Bisulfite PCR confirmation of meDIP-seq results
In order to validate the meDIP-seq results, we turned to
the gold standard bisulfite-sequencing technique to exam-
ine the methylation patterns at single-base pair resolution
for a few predicted chomosomal loci. Bisulfite treatment
of DNA induces deamination of cytosine to uracil, which
is sequenced as thymine [58]. The deamination of cytosine
to uracil is blocked by methylation [58,59]; therefore,
when analyzing PCR product sequences from bisulfite-
treated samples, we infer that any cytosines that are not
changed to thymine must have been methylated originally.
It is important to keep in mind that methylcytosine and
hydroxymethylcytosine are indistinguishable by bisulfite
sequencing [60]. We performed bisulfite-PCR on two
independent O. trifallax samples: the 46 h DNA used for
meDIP and an independently staged 40 h DNA sample.
As a negative control, we used vegetative O. trifallax DNA
from strains JRB310 and JRB510, which are compatible
mating types that are mixed to initiate conjugation. In
most organisms, cytosine methylation occurs at specific
motifs (CpG, CpHpG or CpHpH), so standard bisulfite-
sequencing oligos are designed with non-CpG cytosines
converted to thymine. However, we observed virtually no
methylation (less than 0.5% of cytosines) in bisulfite-con-
verted 40 h DNA with the cytosine-to-thymine converted
oligos (Additional file 4a). However, using cytosine-retain-
ing oligos for PCR of bisulfite-converted 40 h or 46 h
DNA yielded detectable bands that were not observed in
vegetative DNA; sequencing of these bands confirmed
heavy non-CpG methylation (Additional file 4b). The
methylation levels were variable but quite high: cytosine
residues in Contig4414 were 91% methylated on the for-
ward strand and 84% on the reverse, suggesting a potential
strand bias for modification.
Given the meDIP-seq data prediction of hydroxymethy-
lation of the 170 bp satellite repeat (Additional file 3), we
also tested the 170 bp repeat by bisulfite-PCR and con-
firmed that this repeat is highly modified in 40 h or 46 h
cells, but no band is detectable in bisulfite-treated DNA
from vegetative cells (Figures 6a,b and 7a). Sequencing of
these PCR products showed that the 170 bp satellite was
methylated or hydroxymethylated at 71% and 54% of
forward- and reverse-strand cytosines, respectively (Addi-
tional file 4c). The same pattern held for the well-known
and abundant TBE1 family of transposable elements
(Figure 6a), confirmed by clone sequencing (Additional
file 4e). While the TBE1 transposon sequences were not
sufficiently enriched in meDIP-seq reads to be included in
Additional file 1, either the transposase or 22 kDa ORF
[61] encoded in the related TBE2 transposon were present
in the methylation or hydroxymethylation cohorts, respec-
tively. One explanation for the absence of TBE1 from
these cohorts may be the lower sensitivity of meDIP-seq
relative to bisulfite-PCR sequencing.
When we analyzed the sequencing traces from bisulfite-
PCR of 40 or 46 h cells, the methylation (or hydroxymethy-
lation) was present at all residues within the amplified
regions of most molecules, interspersed with occasional,
apparently unmodified cytosine residues (Figure 6c).
Careful examination of patterns of modification in
Contig4414.0 (Figure 6c), or the MIC-limited 170 bp satel-
lite repeat (Additional file 4c) or a TBE1 transposon
(Additional file 4e), revealed runs of 3 to 8 consecutive
unmethylated cytosines in some sequencing reads. This
tendency of the putative methyltransferase to skip some
consecutive cytosines suggests either that the activity is
processive and may occasionally fall off the DNA, or that
methylation could potentially be blocked by an unknown
DNA-binding factor or different modification at these sites,
effectively leaving a footprint. However, since every cyto-
sine displayed either methylation or hydroxymethylation in
at least some DNA molecules, we infer that any block to
methylation is not consistent across the chromosomes.
The observation that methylation occurred regionally, with
high consistency on cytosines in all sequence contexts, sug-
gests that deposition may occur in a processive fashion.
These observations are also consistent with reports of
high-density methylation in all sequence contexts of local
genomic regions in the fungi Neurospora crassa [62] and
Uncinocarpus reesii [1].
The identification of an enriched motif in our data, in
the form of the CC motif (Figure 4c), raises the possibility
that specific motifs facilitate the loading of a processive
DNA methyltransferase onto DNA in O. trifallax. The fact
that methylation of all cytosines can extend for hundreds
of base pairs (1 kb, for TBE1 transposons, was the maxi-
mum in our dataset; Additional file 4e) suggests that the
enzyme may stably associate with DNA. It is still a mystery
how these methylated MIC sequences are targeted, since
they do not contain the CC motif identified in the meDIP-
seq analysis. Because MIC-limited repetitive sequences are
difficult to assemble, we cannot exclude the possibility
that the CC motif or other methyltransferase-recruiting
motifs might be present in the nearby genomic context, or
that there might be some other targeting mechanism for
these sequences.
The use of cytosine-retaining oligos for bisulfite-PCR
raised a concern that non-converted unmethylated DNA
present at a low level in bisulfite-treated samples might
have been erroneously identified as methylated. We
addressed this concern in two ways: first, we always per-
formed bisulfite-PCR on vegetative DNA as control (from
strain JRB310, JRB510 or both; Figure 6a,b), and second,
we used qPCR to quantify the level of signal in a given
bisulfite-treated sample, which was compared to a known
unmethylated control. Our results were consistent: vegeta-
tive DNA never amplified detectable levels of product in
ten different primer sets (Figure 6a,b). Similarly, qPCR of
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Figure 6 Confirmation of predicted methylation by bisulfite sequencing. (a) Use of C-to-T converted primers specifically amplifies the non-
methylated chromosomes from bisulfite-treated 40 h (hour) or vegetative DNA (labeled ‘Non-methylated’), while standard, cytosine-retaining
primers amplify methylated DNA (labeled ‘Methylated’). PCR of TEBPb was performed on native DNA to demonstrate functionality of the oligos.
(b) A repeat of the experiment in (a), but with a 46 h, not 40 h, sample, and with additional methylation cohort chromosomes, as well as TEBPa
and TEBPb. Strains JRB310 (310) and JRB510 (510) are two mating types of Oxytricha trifallax whose mixing induces conjugation; the 40 h and
46 h samples are an equal combination of both mating types. (c) Bisulfite sequencing of eleven Contig4414.0 clones. Cytosines in bold are
methylated. Note that methylation occurs in all sequence contexts and can have runs of consecutive skipped residues. Two CC motifs occur in
this region of the chromosome, as marked. (d) Three aberrantly spliced, and methylated/hydroxymethylated, versions of TEBPa identified by
bisulfite-PCR of 46 h DNA. MDS 12 would normally never be fused directly to MDS 2, as observed in these products; 3 to 4 bp cryptic pointers
(marked ‘cp’ in red arrowheads) are present at recombination junctions. Normal unscrambling entails fusion of MDS 1 to MDS 2 and MDS 12 to
MDS 13; wild-type pointers for these events are marked in turquoise arrowheads. Products 2 and 3 (recovered 1 and 2 times, respectively)
appear heavily methylated, while product 1 is more lightly methylated (G to A substitutions indicate C to T conversions on the opposite strand,
highlighted in pink). Colored nucleotides differ from the WT sequence (top). PCR primers are marked by purple arrowheads. MDS, Macronuclear
Destined Sequence; TEBPa, Telomere End-Binding Protein a; Veg, vegetative.
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bisulfite-treated vegetative DNA generally gave threshold
cycle (Ct) values close to a water control (35 to 38 cycles)
and close to a non-methylated PCR product used as a
bisulfite conversion control (Figure 7a). The 2^-ddCt
method for measuring differential qPCR signal is ideally
suited to quantitative measurement of both methylated 46
h DNA and unmodified residual DNA from vegetative
O. trifallax samples [63]. As a proof-of-concept for the use
of bisulfite-qPCR for O. trifallax, we normalized each
bisulfite-treated qPCR cycle count value to itself in native,
non-bisulfite converted form.
The 2^-ddCt method quantifies the loss of qPCR signal
induced in a sample by bisulfite treatment, and the differ-
ence in this loss between vegetative and 46 h DNA consti-
tuted the methylation signal in the sample. It is clear from
the data plotted in Figure 7a that many samples yielded
signals between 30- and 1000-fold higher in 46 h DNA
than in vegetative DNA. To consider a chromosome vali-
dated, we required a statistically significant difference (p <
0.05, Student’s one-sided t-test for unequal variance) in
signal between 46 h and vegetative control (Figure 7a;
boldface in Additional file 1). In total, these methods vali-
dated 5 of 11 methylation cohort chromosomes at a statis-
tically significant level (including Contig5413.0, which
initially failed to amplify by ordinary bisulfite-PCR (Addi-
tional file 1)).
In addition to the validated methylation cohort chromo-
somes, bisulfite-qPCR confirmed methylation in two
additional MAC chromosomes and two MIC loci: telo-
mere-end binding protein a (TEBPa, p < 0.05) and TEBPb
from the MAC, and TBE1 (p < 0.05), and the 170 bp satel-
lite repeat (p < 0.05) from the MIC (Figure 7a). The mito-
chondrial rRNA locus was neither methylated nor
hydroxymethylated, and therefore it served as a load con-
trol in all subsequent analysis. We attribute the noise
observed in the methylation cohort member Contig604.1
to non-specificity of the primers, although we note that
the overall trend suggested methylation. Contig4510.0 was
a negative control, predicted to be neither methylated nor
hydroxymethylated, based on the meDIP-seq data, but its
primers appear nonspecific, making the qPCR data difficult
to interpret.
TEBPa was not expected to show cytosine methylation,
since it was not included in any meDIP-seq cohort.
Further analysis (described in the next section) revealed
that this methylation appears most likely to be specific to
aberrantly processed isoforms. In contrast to TEBPa,
TEBPb was predicted to be hydroxymethylated in the
meDIP-seq experiment, and this was validated by bisulfite-
qPCR, with approximately 50-fold more signal in 46 h
DNA (Figure 7a). All primer sets used in qPCR were
designed to cover peaks observed in the meDIP-seq data
(Figure 5a, qPCR primers shown as grey arrows), demon-
strating that these data are a rich resource for investigating
DNA methylation. For example, Contig5413.0 demon-
strated no signal in standard bisulfite-PCR (Figure 6b;
using the teal-colored primers marked in Figure 5a); how-
ever the more closely spaced qPCR primers shown in
grey in Figure 5a did detect evidence of methylation
(Figure 7a), suggesting that the DNA modifications may
be quite localized (within a few hundred base-pairs). Simi-
larly, bisulfite-qPCR of TEBPb only recovered a product
when primers targeted the meDIP-seq peaks correspond-
ing to predicted modifications (Figure 5c, grey arrows, and
Figure 7a). We attribute the success of these bisulfite-
qPCR assays to both the sensitivity of qPCR and the relo-
cation of primers to specific sites predicted to be modified
in the genome.
DNA methylation or hydroxymethylation marks
aberrantly rearranged molecules
Despite the fact that O. trifallax genome rearrangements
are exquisitely programmed by noncoding template
RNAs[64], errors of rearrangement occur with surprising
abundance during early macronuclear development (but
not in mature cells) [64,65], and so produce an additional
class of DNA that requires elimination. Typical aberrant
rearrangement products include internal deletions within
a macronuclear chromosome, when regions that are nor-
mally retained are instead effectively treated as if they
were precursor (micronuclear-limited) sequence, and
removed as a false IES [64,65]. Both programmed and
aberrant DNA rearrangement in O. trifallax occur
between regions of microhomology known as pointers
[64,65], and this leads to deletion of the intervening DNA
sequence and retention of one copy of the pointer. Such
errors can be deleterious when portions of coding
sequence are removed or frameshifts are produced; how-
ever, the high DNA copy number in the MAC means
that copies of correctly-processed genes may also be
present.
Bisulfite-PCR recovered three different aberrant TEBPa
rearrangement products from 46 h DNA, using primers
spanning a shorter, scrambled precursor region for this
gene (MDS 12 to 2; Figure 6d). In all three cases, IES6,
which is normally removed via unscrambling of this locus,
was deleted as a conventional IES instead, with subsequent
rejoining of flanking DNA at different 3-4 bp cryptic poin-
ters but no segment reordering (Figure 6d). Importantly,
all three of these aberrant products displayed evidence of
methylation (Figure 6d). Clone 1 was relatively hypo-
methylated in the surveyed region, but one G was retained,
signifying a methylated cytosine on the reverse strand.
Further, the amplification of the product from bisulfite-
treated DNA suggests that the primer binding sites were
also mostly methylated, although this information is
absent from the sequencing data because primer binding
site methylation cannot be sequenced from PCR products.
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Figure 7 The use of bisulfite-qPCR to detect methylated/hydroxymethylated DNA and loss of methylation after decitabine treatment.
(a) Validation of bisulfite-qPCR for Oxytricha trifallax DNA. The ddCt method was used to quantify the loss of signal induced by bisulfite
treatment relative to signal from an equal amount of untreated DNA. Signal was normalized to total DNA used as input for the bisulfite
treatment. A PCR fragment of Contig4414 amplified from vegetative (nonmethylated) DNA provided the conversion control (negative control for
methylation); two indepdendent bisulfite treatments of this PCR product, A & B, were used as templates in qPCR. All qPCR was performed in
triplicate and the average is plotted with standard error. The Student’s 1-tailed t-test for unequal variance was used and p-values are indicated:
*, p < 0.05; **, p < 0.01, ***, p < 0.005. Values marked *** in Figures 7 and 8 appear significant even with a correction for multiple tests.
(b) Staging data for 40 h decitabine (dAza)-treated cells. Cells were fixed and DAPI stained to allow staging based on nuclear morphology as in
Figure 2e. (c) Bisulfite-qPCR analysis of decitabine-induced demethylation in 40 h cells. Both native (red bars) and bisulfite-converted DNA (green
bars) are shown, normalized to native mitochondrial rDNA signal (for loading) and to untreated cells (grey bars) to determine fold change. All
qPCR was performed in triplicate and the average is plotted with standard error. Statistical test for significance was carried out with Student’s
1-tailed t-test (*, p < 0.05; **, p < 0.01, ***, p < 0.005). DAPI, 4’,6-diamidino-2-phenylindole; qPCR, quantitative PCR; Veg, vegetative.
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We infer that clones 2 and 3 derived from heavily methy-
lated regions, because all cytosine and guanosine residues
other than the primer binding sites were present and thus
methylated.
Consistent with these observations, bisulfite-PCR from
40 h cells recovered a fourth aberrant product from
another gene, TEBPb, that appeared to be methylated or
hydroxymethylated at most cytosines. This product also
displayed the same features of recombination between
cryptic pointers (not shown) that are typical for aberrant
rearrangement products; however, its sequence was simi-
lar but not identical to another aberrant rearrangement
product studied in our laboratory, and so we have weaker
confidence in this example.
Bisulfite-PCR of TEBPa from MDS14 to 15, on the
other hand, produced an unexpected, faint double band
from 46 h DNA (Figure 6b). Cloning and sequencing indi-
cated that the double band represented both the MIC
(longer) and MAC (shorter) versions of the gene, and that
both were highly methylated (or hydroxymethylated)
(>70%). However, it is possible that this methylated por-
tion of micronuclear sequence was derived from an aber-
rantly spliced product rather than the micronucleus itself,
since we cannot infer the structure of flanking DNA seg-
ments from PCR products. Althrough this example could
be a rare case of methylation in the MIC genome during
development, we favor the simpler model that the bisul-
fite-resistant MAC and MIC versions we detected were
derived from stalled aberrant rearrangement products that
amplified with the MDS 12 - MDS 2 primer pair.
Treatment with azacytidine and deoxyazacytidine inhibits
elimination
Overall, the above findings are significant because they
link three types of eliminated DNA (parental macronuc-
lear chromosomes, aberrantly rearranged chromosomes
and repetitive germline-limited sequences) to conjugation-
specific cytosine methylation/hydroxymethylation, sug-
gesting that a functional role for these DNA modifications
might be to mark sequences for elimination. We therefore
performed experiments designed to test the functional
role of DNA methylation during the genome rearrange-
ment process.
Inhibitors of DNA methylation have been developed
and used as therapeutic agents against myelodysplastic
syndrome, or preleukemia in common parlance [66-69].
The most well known of these agents are azacitidine and
decitabine, a nucleoside analog and a deoxynucleoside
analog, respectively, of cytidine. Both drugs function by
becoming incorporated into the DNA during replication,
but they cannot be methylated because they contain a
nitrogen atom at position 5 in the pyrimidine ring, pre-
venting the addition of a methyl group at this site. Impor-
tantly, azacitidine and decitabine also form covalent
adducts with DNA methyltransferases, which leads to
proteasomal degradation of these enzymes and, conse-
quently, results in a general block of the DNA methyla-
tion process [70]. It is expected that inhibition of DNA
methylation would also lead to reduced DNA hydroxy-
methylation, since the latter forms through oxidation of
pre-existing methyl groups, and so is dependent on the
presence of methylation [41]. Given our hypothesis that
DNA methylation in O. trifallax has a function in the
genome rearrangement process, we asked whether treat-
ment of cells with drugs to inhibit DNA methylation
would, in turn, inhibit DNA elimination.
Because the effects of inhibiting DNA methylation in
human tissue culture have been extensively characterized
(see, for example, [22,23,71,72]), the drug concentrations
needed for biological effects in tissue culture were already
available to us. First, we tested whether treatment of
O. trifallax cells with decitabine (0.1 μM, 0.4 μM, or
1 μM) could induce demethylation of validated methyla-
tion cohort chromosomes. Cells were grown vegetatively
for 48 h either in untreated media or media suplemented
daily with fresh decitabine, which has a relatively short
half-life in aqueous solution. As expected, we did not
observe any morphological defects during vegetative
growth, consistent with a lack of detectable DNA methy-
lation during this portion of the lifecycle (Figures 2a, 6a,b
and 7a). Next, we induced conjugation by mixing mating
types, and at this point we added fresh decitabine to the
cultures. Cells were allowed to progress through genome
rearrangements (no additional drug was added during
the conjugation and rearrangement process) and assayed
at 40 h for methylation status. Because our data suggest
that methylation levels vary with developmental stage
(Figures 2a,b, 3b,c, 6a,b and 7a), it was important to mea-
sure the stages of these cells precisely. The staging of the
cells was quite consistent between treatments (Figure 7b)
with approximately 60% S3 and approximately 30% S4
cells in each sample. We conclude that these concentra-
tions of decitabine do not induce developmental delay or
arrest.
To assess methylation in the decitabine-treated cells,
DNA was extracted from the 40 h populations shown in
Figure 7b, bisulfite treated and assayed by qPCR of various
methylated/hydroxymethylated loci. Of 11 tested loci, 7
displayed a statistically significant reduction of DNA
methylation in at least one decitabine-treated sample
(Figure 7c); one of these loci was the 170 bp satellite repeat
shown to be hydroxymethylated by both meDIP-seq and
bisulfite sequencing (Additional file 3, Figure 6a,b). The
methylation levels of 4 out of 7 tested methylation cohort
chromosomes were significantly reduced. The top candi-
date, Contig2927.0 (Additional files 1 and 3), only displayed
a statistically significant demethylation in the 1 μM-
treated sample, and this reduction was relatively mild.
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However, Contig15988 (Alba protein), Contig18539 (col-
lagen) and TEBPb were more robustly demethylated.
Contig10532 (unknown protein) showed a possible trend
toward reduced methylation but was not statistically signif-
icant in this experiment, and methylation levels of Con-
tig11442.0 (6× RRM-containing) were unaffected by
decitabine treatment, although it is possible that higher
doses of drug or longer treatment length might have pro-
duced an effect. We also observed a modest accumulation
(1.5- to 2-fold) at 40 h of the same chromosomes whose
methylation was reduced (native DNA in Figure 7c, Addi-
tional file 1). Four chromosomes had statistically significant
(p < 0.05) increases in DNA copy number, while five more
showed an increase that was not statistically significant
(Figure 7c). Together, these data suggested a possible cou-
pling between DNA methylation and degradation, although
at the tested drug concentrations the block of methylation,
and hence degradation, was incomplete. Overall, the results
were consistent with the fact that the cells did not arrest in
development (Figure 7b).
We next tested whether inhibition of DNA methylation
would cause long-term retention of genomic sequences in
exconjugant cells. This time we included azacitidine in the
drug regimen along with decitabine, and we allowed the
cells to complete genome rearrangements, harvesting
them at 88 h post-mixing, when rearrangements are
largely complete (Figure 8a). For each population, we
assessed the proportion of cells in each stage as a measure
of developmental lag (Figure 8a) and observed that vegeta-
tive cells or cysts accounted for 90% of most populations,
while 10% of cells were still in S4. The 6 μM azacitidine-
treated cells did display a slight developmental delay
(Figure 8a); however, since no delay was observed in the
10 μM-treated cells, this may not have been related to the
drug treatment, or this may have been the optimal concen-
tration for the drug to have effect. Nevertheless, the lag-
ging cells in the 6 μM culture might have increased the
germline sequence abundance and so this sample must be
interpreted carefully. The other samples did not contain
developmentally delayed cells (Figure 8a).
We observed a strong azacitidine-induced retention of
the TEBPa MIC gene and the two repetitive MIC-lim-
ited elements (170 bp satellite and TBE1 transposon)
(Figure 8b). While some of this effect might have been
due to delayed development in the 6 μM sample, delay
cannot account for the observed accumulation in other
samples (Figure 8b). Furthermore, the 6 μM azacitidine
sample also displayed a surprising accumulation of two
MAC chromosomes (Contig 18539 and Contig15988),
which is unlikely to result from developmental delay.
These may instead represent a retention of parental
MAC chromosomes that were not eliminated, due to
methylation defects in caused by azacitidine treatment.
Decitabine showed a weaker effect on repetitive DNA
(Figure 8b). There was a mild retention of the 170 bp
repeat but no effect on the TBE1 transposon; we also
observed a retentive effect at the TEBPa MIC locus. We
have performed this experiment twice and observed consis-
tent retention of the 170 bp satellite repeat (Figure 8d;
these data are from the experiment in Figure 7c that
confirmed demethylation). However, TBE1 retention
with decitabine treatment was not consistent (compare
Figure 8d to Figure 8b). Retention of the 170 bp satellite
was observed independently three times in exconjugant
cells treated with azacitidine (two of these experiments are
shown in Figure 8b,c and Additional file 5).
Several non-repetitive sequences showed consistent
accumulation with drug treatment. The scrambled MIC
version of TEBPa showed consistent elimination defects
in all three experimental replicates of azacitidine treat-
ment (2 of 3 replicates are shown in Figure 8b and 8c),
although this effect was not observed in either decitabine
experiment (compare Figure 8b,d to Figure 8b,c). Azaciti-
dine induced an accumulation of Contig15988 in both
experiments in which it was surveyed (only one shown,
Figure 8b), while treatment with decitabine resulted in
decreased levels of the same chromosome (Figure 8d).
Some MAC chromosomes consistently exhibited a mild
decrease in DNA copy number in exconjugants. The
MAC version of TEBPa was depleted upon azacitidine
treatment in three independent experiments, and a
decrease in Contig4414.0 was observed in two azacitidine
experiments (it was not measured in the third experiment)
(Figure 8b and not shown). We interpret these results as
evidence of partial stalling during genome rearrangement,
with a failure to regenerate the correct levels of several
new macronuclear chromosomes.
Discussion
DNA methylation plays pivotal roles in development and
cell lineage differentiation in plants and animals [1,3-6].
While our knowledge of DNA methylation pathways in
animals, plants and fungi is relatively advanced, very little
is known about DNA methylation in microbial eukar-
yotes, such as ciliates. Though early work uniformly
failed to identify cytosine methylation in Paramecium
aurelia, T. thermophila, or O. trifallax [73-75], we have
here identified both methylcytosine and hydroxymethyl-
cytosine as vital players in the genome rearrangement
process of O. trifallax. We have unambiguously identified
these modifications using high-sensitivity nano-flow
UPLC-MS, and have tested their functionality by pre-
venting their formation using methyltransferase inhibi-
tors. Because earlier work examined vegetative samples
of O. trifallax, which we confirm are lacking in both
methylcytosine and hydroxymethylcytosine, it did not
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Figure 8 Effects of decitabine and azacitidine treatment on genome rearrangement in Oxytricha trifallax. (a) Staging of 88 h
exconjugant cell populations treated with azacitidine or decitabine, using criteria from Figure 2e. (b) qPCR to measure relative levels of MIC or
MAC loci in the same cells staged in (a). Blue bars represent azacitidine-treated populations, red bars represent decitabine-treated populations,
and grey bars are untreated controls, set to 1. All qPCR was performed in triplicate and the average is plotted ±standard error. The Student’s
1-tailed t-test for unequal variance was used to measure statistical significance (*, p < 0.05; **, p < 0.01, ***, p < 0.005). (c) Replicate experiment
showing reproducible accumulation of MIC DNA, and less processed MAC DNA, in azacitidine-treated exconjugants. (d) Replicate experiment
showing reproductible accumulation of micronuclear MIC DNA and less MAC DNA in decitabine-treated cell populations. All labeling is as in
(a). MAC, macronuclear; MIC, micronuclear; qPCR, quantitative PCR; Veg, vegetative.
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detect the de novo methylation and hydroxymethylation
that we show occurs only transiently during genome
rearrangements. Supporting these observations, a report
in 2003 described de novo methylation in the stichotri-
chous ciliate (and close O. trifallax relative) Stylonychia
lemnae [76]. In that work, though detected at low levels
in vegetative MIC, cytosine methylation was detectable
primarily during the genome rearrangement processes,
where it was introduced de novo within eliminated trans-
poson-like sequences [76]. As in the O. trifallax system,
methylation was observed in all sequence contexts within
the transposable element, and was clustered in a region
spanning approximately 500 bp [76]. While our results
generally support the conclusions of the S. lemnae study,
our work differs in some important ways: firstly, since
hydroxymethylation had not yet been identified as an
important epigenetic mark in DNA, it was not analyzed in
S. lemnae; secondly, O. trifallax DNA methylation/hydro-
xymethylation occurs at a much higher level (70%-90%)
than reported in S. lemnae (25%); thirdly, O. trifallax has
significant modification of at least a few macronuclear
chromosomes and aberrant splicing products, neither of
which was reported for S. lemnae; fourthly, the data pre-
sented here directly implicate methylation/hydroxymethy-
lation in O. trifallax’s DNA elimination pathway; and,
fifthly, we report a 20 bp motif that appears to play a role
in directing methylation/hydroxymethylation to particular
regions of specific chromosomes. We demonstrate that
the DNA methylation process plays a significant functional
role in the elimination of repetitive sequences in the MIC,
including a highly abundant transposon family and an
abundant satellite repeat family. We also report the speci-
fic methylation/hydroxymethylation of a small number of
aberrantly rearranged molecules but not their correctly
rearranged counterparts, suggesting a role for DNA modi-
fication in either error recognition during chromosome
rearrangement and/or the degradation of such incorrectly
rearranged molecules.
Functional data presented here support a role for DNA
methylation in degradation pathways, because methyla-
tion appears enriched in DNA from the parental MAC,
which is targeted for elimination, as well as repetitive
MIC eliminated sequences. We found that inhibition of
DNA methyltransferases by decitabine led to significant
demethylation of 6 out of 9 MAC chromosomes and one
MIC locus (the 170 bp satellite repeat; Figure 7c). Coinci-
dent with the decitabine-induced loss of methylation
from these chromosomes, we observed a mild but often
statistically significant accumulation of the chromosomes
themselves (the native DNA signal in Figure 7c). While
this accumulation is modest, with a maximum 1.5- to
2-fold increase, these data provide compelling support
across multiple chromosomes for an intimate link
between DNA methylation/hydroxymethylation and
degradation during genome rearrangement.
Further support for the model comes from the exami-
nation of cells that have completed genome rearrange-
ments after azacitidine and decitabine treatment: 170 bp
satellite repeats and TBE1 transposons display a statisti-
cally significant accumulation relative to untreated con-
trols (Figure 8b,c,d). In addition, azacitidine treatment
induces an accumulation of germline TEBPa and a
decrease in MAC versions of the same gene (Figure 8b, c).
We observe other genome rearrangement defects upon
azacididine or decitabine treatment: along with TEBPa,
Contig4414 also shows lower levels, while two other chro-
mosomes showed elevated levels (Contig18539 and Con-
tig15988), consistent with retention of parental MAC
chromosomes that were not degraded properly. These
data demonstrate the complexity of the functional conse-
quences of inhibiting DNA methylation: effects may be
direct (such as a failure to degrade a given molecule of
DNA from the parental MAC) or indirect (for example, if
the cell cannot properly eliminate an IES from the MIC
version of a gene and therefore does not produce enough
MAC product). Further work is needed to disentangle
these effects but, taken together, the data implicate a DNA
methylation/hydroxymethylation pathway in the elimina-
tion of repetitive and single-copy elements from the MIC
genome and in the production of a functional macronuc-
lear genome.
The relationship between cytosine methylation and
hydroxymethylation in O. trifallax offers new challenges.
In mouse, for example, sperm DNA is methylated but
paternal genome methylation is rapidly lost upon fertili-
zation [77], as the embryo undergoes epigenetic repro-
gramming and establishment of new methylation patterns
[78,79]. Hydroxymethylcytosine appears in the paternal,
but not maternal, pronucleus during this dramatic
re-writing of the epigenetic code [80,81], coincident with
the loss of paternal methylation. Other work has linked
hydroxymethylation with tissue-specific promoter activa-
tion and, presumably, demethylation during development
[82]. Hydroxymethylation is dependent upon pre-existing
methylation and so exists in a dynamic tension with it:
both modifications can mark the same genomic regions
[83], as we see in O. trifallax, and this phenomenon is
particularly prevalent in embryonic stem cells [84,85]. Yet
hydroxymethylation also antagonizes methylation by
directing its removal and/or blocking methylcytosine-
binding heterochromatin proteins [86,87]. The link
between methylation and degradation in O. trifallax sug-
gests that the organism might use hydroxymethylation as
a countervailing, stabilizing force, perhaps to target genes
that are important for conjugation. Other mechanisms
may also be involved in this association: O. trifallax’s
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most hydroxymethylated ribosomal protein gene is a
homolog of L12, which in bacteria and yeast can regulate
ribosome initiation and elongation [88,89]. Therefore,
changes in expression of the L12-encoding chromosome
may have ramifications across the proteome, possibly
even shutting down translation while the organism
undergoes the elaborate steps of genome remodeling.
Conclusions
In conclusion, we have observed three different types of
DNA marked with cytosine methylation in O. trifallax:
chromosomes targeted for degradation in the parental
macronucleus, micronucleus-limited repetitive elements
and aberrantly spliced gene rearrangement products. Aza-
citidine or decitabine treatment significantly inhibited the
elimination of at least some sequences, coincident with
reduced methylation. The work presented here reveals a
novel pattern of extensive cytosine DNA methylation and
suggests a functional link to DNA degradation, while also
providing a first glimpse into a methylation-based error-
detection pathway in O. trifallax.
Previous literature reporting the absence of methylctyo-
sine in ciliates [73-75,90] makes our results surprising.
However, these earlier studies exclusively surveyed vegeta-
tive cell DNA, whereas a more recent study that examined
conjugating DNA [76] did detect low levels of methylcyto-
sine, although (as discussed above) no functional role was
defined and the levels of modification were much lower
than reported here. We do not detect any homologs of the
canonical DNA methyltransferase genes (DNMT1, 3A, 3B,
or 3L, Dim-2, or the plant-specific methyltransferases
CMT3, DRM1/2, and MET1 ) [1,3,4,91] in the macronuc-
lear genome of O. trifallax [92], suggesting that the
enzyme might be encoded in the micronucleus or on a
rare macronuclear chromosome that was excluded from
the macronuclear genome assembly (Swart et al., manu-
script in revision). However, a search of the current draft
micronuclear genome which contains 95% of macronuc-
lear sequences (J.R.B, L.F.L. and X. Chen, unpublished
data) revealed no additional candidate methyltransferases.
In contrast to the absence of DNA methyltransferases,
we can identify a macronuclear family of Tet (Ten-eleven
translocation) dioxygenases resembling those involved in
hydroxymethylation in other systems [41,85], as well as a
homolog of the DNA methyltransferase-binding protein
(DMAP1) [93]. This protein has been reported to activate
DNMT1 at sites of DNA breakage during homologous
recombination [94]. The association of DMAP1 with an
unknown DNA methylase could help O. trifallax distin-
guish between aberrantly spliced products and their correct
versions, ensuring that only the former are methylated.
The observation that DNA rearrangements in O. trifallax
and S. lemnae are rife with errors during early nuclear
development [65] necessitated a mechanism to correct or
eliminate aberrant products, and prompted our laboratory’s
previous discovery of the long, noncoding RNAs that sup-
ply templates for error correction [64]. While the mechan-
ism by which the cell detects aberrantly spliced DNA is
unknown, DNA methylation, perhaps coupled with non-
coding RNA guides, provides an elegant mechanism to
mark DNA splicing mistakes for future degradation, along
with other genomic sequences to be eliminated.
Materials and methods
O. trifallax culture
O. trifallax mating types JRB510 and JRB310 were cul-
tured separately in Pringsheim media, the volume of
which was doubled every day, and with Chlamydomonas
reinhardtii as a food source, supplemented daily with
fresh overnight cultures of Klebsiella pneumoniae. For
conjugations, very lightly starved cells were gauze filtered
to remove algae clumps. A very small amount of K. pneu-
moniae culture was added (approximately 5 μl in a 300
ml dish) to promote conjugation. The cells form maximal
pairs at approximately 12 h post-mixing and separate by
24 h post-mixing. The cells were harvested by killing
with 25 mM EDTA, centrifuged for five minutes at 5,000
rpm, and resuspended in buffer T1 of the Nucleospin
Tissue Kit (#740952.250, Macherey-Nagel, Bethlehem,
PA, USA). The standard protocol was followed for DNA
preparation (proteinase K treatement, lysis and purifica-
tion over a column).
Immunofluorescence
Twelve-well slides were incubated overnight with 20 mg/ml
polylysine in a moist chamber. The wells were washed with
water and fixed O. trifallax cells (4% paraformaldehyde, 10
to 15 minites, 2× PBS wash) were allowed to adhere to the
slides overnight. Cells were permeabilized for 20 minutes
with 0.5% Triton-X100 in PBS, then incubated for five min-
utes with 0.1 N HCl. After washing again, the Image-iT
signal enhancer (cat#I36933, Invitrogen, Grand Island,
NY, USA) was added to the cells for 30 minutes. The cells
were washed, incubated with primary antibody for 1 h at
room temperature, then washed for 20 minutes, followed
by secondary antibody incubation (1:800 goat anti-mouse
or -rabbit; labeled with AlexaFluor 488 or 568) for 1.5 h at
37°C. The cells were washed twice more with PBS, then
stained with DAPI (1 to 2 ng/μl in PBS) for two to three
minutes. Cells were washed three times with PBS, then
mounted with Aqua-Poly/Mount (Polysciences, Warring-
ton, PA, USA), and a coverslip was added. Imaging was
performed with a confocal microscope at the Princeton
University Microscopy Facility. A mouse anti-methylcyto-
sine antibody (33D3, ab10805, Abcam, Cambridge, MA,
USA) was used at 1:100 dilution and a rabbit anti-hydro-
xymethylcytosine antibody (#39792, ActiveMotif, Carlsbad,
CA, USA) was used at 1:500 dilution.
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Methylcytosine immunoprecipitation and deep
sequencing
All steps were performed as described [44]. We used a
Covaris machine (Covaris, Woburn, MA, USA) for frag-
mentation of 10 μg of 46 h or an equal mixture of
JRB310 + JRB510 DNA to 300 bp (10% duty cycle, inten-
sity = 4,200 cycles per burst, 80 seconds). We performed
Illumina library adaptor ligation (Illumina, San Diego,
CA, USA) before immunoprecipitation, using different
indexes for 46 h and vegetative DNA; these libraries were
mixed prior to immunoprecipitation and no PCR steps
were performed until after IP to avoid loss of DNA modi-
fications. The pooled libraries were subjected to immu-
noprecipitation using the same anti-methylcytosine and
anti-hydroxymethylcytosine antibodies used for immuno-
fluorescence, described in the previous section, or control
IgG (mouse). Immunoprecipitation was carried out with
Dynabeads Protein A (Invitrogen, Grand Island, NY,
USA) and a magnetic capture system. After immunopre-
cipitation as in [44], PCR amplification of the captured
material was performed with Illumina adaptor primers by
Phusion Hot Start Flex (New England Biolabs, Ipswich,
MA, USA) (15 cycles, 60° annealing, 30 second extend),
followed by size-selection on a 2% MetaPhor (Cambrex,
East Rutherford, NJ, USA) agarose gel to eliminate adap-
tor dimers and size-select the library. Sequencing was
performed on a HiSeq2000 (Illumina, San Diego, CA,
USA) at the Princeton University Microarray Facility and
approximately 5 to 8 million sequences were obtained for
each library. Data were mapped with BWA [95] and the
resulting SAM files were custom parsed with custom
Python scripts to produce the scatter plots shown in
Figure 4. Both raw read files and processed data files are
available on Gene Expression Omnibus (GEO); see Data
Availability section for more information.
Treatment of O. trifallax with azacitidine and decitabine
Cells were grown and cultured as described above, with
separate dishes for each drug concentration. Every day a
fresh 500 μM stock of azacitidine or decitabine was
prepared by mixing 0.001 g of powder into 10 ml of
Pringsheim media, and shaking gently for two to five min-
utes. This stock was diluted into the culture dishes
directly when the cells were fed daily or when conjugation
was initiated. Cells were fed the equivalent of 25 ml
C. reinhardtii culture per 100 ml petri dish (containing
25 ml dense ciliate culture), washed twice in Pringsheim
media, and supplemented with 30 μl of fresh K. pneumo-
niae culture. Each day the volume was doubled with fresh
Pringsheim media, and the amount of food was doubled.
On the third day, the cells were filtered through gauze to
remove algae clumps and supplemented with an equal
volume of fresh Pringsheim and 5 μl K. pneumoniae.
Conjugation efficiency and synchrony were quantified by
fixing and DAPI staining some cells for microscopy:
approximately 700 μl of cells were mixed with an equal
volume of a 3:1 Methanol:Acetic acid solution, and
allowed to fix for at least five minutes. The cells were
gently spun down at 200 g for one minute, following
which the supernatant was discarded. A volume of cells
beween 20 and 50 μl was pipetted onto labeled glass cov-
erslips and allowed to air-dry completely (approximately
45 minutes). Once dry, they were either stored or imme-
diately rehydrated and imaged. The rehydration was car-
ried out by floating the coverslips, inverted, for three
minutes on the surface of TE buffer, pH 7.5 (10 mM Tris,
1 mM EDTA) in a petri dish. After three minutes the cov-
erslips were removed and excess fluid blotted off, and
20 μl of a 5 μg/ml DAPI solution was immediately
applied. The coverslips were inverted onto a glass slide
and the edges sealed with clear nail polish to prevent eva-
poration, and were imaged immediately at 400× magnifi-
cation on an inverted microscope. Cells were harvested at
40 h or at 72-94 h with the Nucleospin Tissue kit and the
DNA analyzed by PCR or qPCR, as described above.
Bisulfite-PCR
We used the Cells-to-CpG kit (Invitrogen, Grand Island,
NY, USA) and followed the standard protocol provided in
the kit. In particular, we used a 3× conversion cycle proto-
col (denature, then 65°C for 30 minutes, 95° 1.5 minutes,
65° for 30 minutes, 95° 1.5 minutes, 65° for 30 minutes,
then desalt and desulfonate). For qPCR, we ran the sam-
ples for 45 cycles on an ABI384 (Applied Biosystems,
Carlsbad, CA, USA) under standard cycling conditions.
We normalized all samples to mitchondrial rDNA and
used the ddCt method [63]. Bisulfite-PCR was carried out
with primers listed in Additional file 6 and FastStart Taq
(Roche, Indianapolis, IN, USA) using the following pro-
gram: 1) 95° 30 seconds 2) 95° 30 seconds 3) 55° anneal,
4) 72° extend for 30 seconds, for 35 cycles 5) 72° for 5 min-
utes, 6) 4° hold. A selection of PCR products were Sanger
sequenced by GENEWIZ (South Plainfield, NJ, USA) and
the traces are presented as supplemental online material
(see Data Availability section).
Southern hybridization
Exconjugant DNA was separated on an ethidium-bro-
mide-stained 0.3% SeaKemGold agarose gel (Lonza,
Walkersville, MD, USA). DNA was depurinated in gel
(0.25% HCl, 20 minutes; soaked twice in 0.4 M NaOH
for 10 minutes to neutralize) and transferred to Hybond
XL membrane (GE Healthcare Life Sciences, Pittsburgh,
PA, USA) in 0.4 M NaOH using a Nytran TurboBlotter
(Schleicher & Schuell, Keene, NH, USA). Labeled probe
was generated via random priming (Prime-It, Stratagene,
Santa Clara, CA, USA) of gel purified PCR product
from O. trifallax strain JRB310. After overnight
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hybridization at 60°C in Church buffer (0.5 M NaPO4,
pH 7.2, 1% BSA, 1 mM EDTA, 7% SDS) the membrane
was washed twice in 0.2 × SSC with 0.1% SDS (30 min,
60°C), wrapped in saran wrap and exposed to a phos-
phorimager screen for 6 h or overnight.
High-resolution nano-flow UPLC-mass spectrometry
Purified O. trifallax DNA was subjected to degradation
into nucleosides by treatment with DNA Degradase Plus
(Zymo Research, Irvine, CA, USA). Methylcytosine and
hydroxymethylcytosine controls were obtained from Zymo
Research where they were generated by PCR with the
appropriately modified nucleotides. Concentrated digest
solutions were diluted to approximately 5 ng/ul using 3%
acetonitrile (ACN)/0.1% formic acid (FA) and placed
directly into autosampler vials. Samples were subjected to
reversed-phase nano-LC-MS and MS/MS performed on a
nano-flow capillary ultra-high pressure HPLC system
(Nano Ultra 2D Plus, Eksigent, Dublin, CA, USA) coupled
to an LTQ-Orbitrap XL hybrid mass spectrometer (Ther-
moFisher Scientific, San Jose, CA, USA) outfitted with a
Triversa NanoMate ion source robot (Advion, Ithaca, NY,
USA). Chromatography was achieved using a 75 μm ×
25 cm column packed in house into a fritted capillary
(Integrafrit, New Objective, Woburn, MA, USA) using
1.7 um C18 BEH resin (Waters, Milford, MA, USA). Sam-
ples were loaded directly on column and separations were
conducted using a linear gradient of A and B solvents (Sol-
vent A: 3% ACN/0.2% FA/0.1% acetic acid; Solvent B: 97%
ACN/0.2% FA/0.1% acetic acid) over 60 or 90 minutes at a
flow rate of approximately 250 nl per minute. Nano elec-
trospray ionization was carried out using the NanoMate
ion source at 1.74 kV, with the LTQ heated capillary set to
200°C. Full-scan mass spectra were acquired in the Orbi-
trap in positive-ion mode over the m/z range of 225 to
1800 and the narrower range of 225 to 300 at an instru-
ment resolution of 100,000. Spectra were typically within a
calibration error of 2 to 3 ppm with respect to absolute
mass accuracy, following external calibration of the instru-
ment. LC-MS data were manually interpreted using Xcali-
bur software (ThermoFisher Scientific, San Jose, CA, USA)
to visualize nucleoside mass spectra and to generate
extracted ion chromatograms by using the theoretical
[M+H] values of the target nucleosides within a range
of ±0.0005 Da. Data are available on OxyDB, the O. trifal-
lax genome database website. See Data Availability section
for details.
Data availability
The DNA immunoprecipitation and high-throughput
sequencing data are available on Gene Expression
Omnibus (GEO) [96]: Accession number [GSE41060].
Sanger traces from bisulfite-PCR sequencing are avail-
able as Additional files 7, 8, 9, 10, 11, 12, 13, 14, 15.
UPLC-mass spectrometry data are available at OxyDB,
the O. trifallax genome database website [43].
Additional material
Additional file 1: The methyl cohort. A list of chromosomes whose
methylation was predicted by meDIP-seq and validated by bisulfite-PCR or
qPCR. Columns labeled as ‘signal’ indicate the number of meDIP-seq reads
at 46 h less the number of reads from vegetative DNA. For columns labeled
‘bisulfite-qPCR’ and ‘40 h dAza demethylated?’, bold font denotes
statistically significant effects relative to vegetative or untreated controls
(Student’s 1-tailed t-test for unequal variance, p < 0.05), while a ‘yes’
indicates an effect that was observed but did not reach statistical
significance. ‘n/a’ indicates that the test was not performed.
Additional file 2: The CC motif cohort. A list of chromosomes containing
three or more CC motifs and that overlap substantially with the methylation
and hydroxymethylation cohorts (Additional files 1 and 3).
Additional file 3: The hydroxymethyl cohort. A list of chromosomes
whose hydroxymethylation was predicted by meDIP-seq, with signal
defined as in Additional file 1.
Additional file 4: Supplemental figure depicting bisulfite-PCR
sequence analysis. (a) Contig4414.0 following bisulfite treatment of 40
h DNA and PCR with C-to-T converted primers, which are not methyl-
specific. (b) Contig4414.0 following bisulfite treatment of 40 h DNA and
PCR with cytosine-retaining (methyl-specific) primers. (c) The 170 bp
satellite following bisulfite treatment of vegetative and PCR with C-to-T
converted primers, which are not methyl-specific. (d) The 170 bp satellite
following bisulfite treatment of 40 h DNA and PCR with cytosine-
retaining (methyl-specific) primers. (e) The transposon TBE1 following
bisulfite treatment of 40 h DNA and PCR with cytosine-retaining (methyl-
specific) primers. TBE1, telomere bearing element 1.
Additional file 5: Supplemental figure depicting Southern analysis for
retention of 170 bp repeat and TBE1 transposon in 72 h azacitidine-
treated cells. (a) Southern hybridization. (b) quantification of (a).
Additional file 6: A table of primers used in this study. All primers
used for bisulfite PCR, bisulfite qPCR and Southern blotting experiments.
Additional file 7: Sanger sequencing data (in FASTA format) for
Figure 6b. Bisulfite-treated TEBPa PCR product, MAC isoforms (smaller)
shown in lane 9. TEBP a, Telomere End-Binding Protein a. MAC,
macronucleus.
Additional file 8: Sanger sequencing data (in FASTA format) for
Figure 6b. Bisulfite-treated TEBPa PCR product, MIC isoforms (larger)
shown in lane 9. TEBP a, Telomere End-Binding Protein a. MIC,
micronucleus.
Additional file 9: Sanger sequencing data (in FASTA format) for
Figure 6c. Contig4414 bisulfite sequences.
Additional file 10: Sanger sequencing data (in FASTA format) for
Figure 6d. Bisulfite sequences of TEBPa aberrantly spliced products. TEBP
a, Telomere End-Binding Protein a.
Additional file 11: Sanger sequencing data (in FASTA format) for
Additional file 4a. Sequences for Contig4414.0 following bisulfite
treatment of 40 h DNA and PCR with C-to-T converted primers.
Additional file 12: Sanger sequencing data (in FASTA format) for
Additional file 4b. Sequences for Contig4414.0 following bisulfite
treatment of 40 h DNA and PCR with cytosine-retaining (methyl-specific)
primers.
Additional file 13: Sanger sequencing data (in FASTA format) for
Additional file 4c. Sequences for the 170 bp satellite following bisulfite
treatment of vegetative and PCR with C-to-T converted primers.
Additional file 14: Sanger sequencing data (in FASTA format) for
Additional file 4d. Sequences for the 170 bp satellite following bisulfite
treatment of 40 h DNA and PCR with cytosine-retaining (methyl-specific)
primers.
Additional file 15: Sanger sequencing data (in FASTA format) for
Additional file 4e. Sequences for the transposon TBE1 following bisulfite
Bracht et al. Genome Biology 2012, 13:R99
http://genomebiology.com/2012/13/10/R99
Page 20 of 23
treatment of 40 h DNA and PCR with cytosine-retaining (methyl-specific)
primers. TBE1, telomere bearing element 1.
Abbreviations
ACN: acetonitrile; bp: base pair; Ct: threshold cycle; DAPI: 4’,6-diamidino-2-
phenylindole; ddCt: delta-delta-Ct; DMAP1: DNA methyltransferase binding
protein; Dnmt: DNA methyltransferase; FA: formic acid; kb: kilobases; MAC:
macronucleus; MIC: micronucleus; IES: Internal Eliminated Sequence; IgG:
immunoglobulin G; LC: liquid chromatography; MDS: Macronuclear Destined
Sequence; MS: mass spectrometry; PCR: polymerase chain reaction; qPCR:
quantitative PCR; TBE: Telomere-Bearing Element; TEBPα: Telomere End-
Binding Protein α; TEBPβ: Telomere End-Binding Protein β; UPLC: ultra high
performance liquid chromatography.
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